NovoCure Ltd — Director's Dealing 2020

May 6, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2020-05-04

Reporting Person: DOYLE WILLIAM F (Director, Executive Chairman)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-05-04	Ordinary Shares	M	58768	$60.48	Acquired	569279	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-05-04	Restricted Stock Units	$0.0	M	58768	Disposed		Ordinary Shares (58768.0)	Direct

Footnotes

F1: Fully vested as of the date hereof.